Results of debridement, antibiotics, and implant retention for periprosthetic knee joint infection supplemented with the use of intraosseous antibiotics

Aims Debridement, antibiotics, and implant retention (DAiR) remains one option for the treatment of acute periprosthetic joint infection (PJi) despite imperfect success rates. intraosseous (IO) administration of vancomycin results in significantly increased local bone and tissue concentrations compared to systemic antibiotics alone. The purpose of this study was to evaluate if the addition of a single dose of io regional antibiotics to our protocol at the time of DAiR would improve outcomes. Methods A retrospective case series of 35 PJi TKA patients, with a median age of 67 years (interquartile range (iQR) 61 to 75), who underwent DAiR combined with io vancomycin (500 mg), was performed with minimum 12 months' follow-up. A total of 26 patients with primary implants were treated for acute perioperative or acute haematogenous infections. Additionally, nine patients were treated for chronic infections with components that were considered unresectable. Primary outcome was defined by no reoperations for infection, nor clinical signs or symptoms of PJi. Results Mean follow-up for acute infection was 16.5 months (12.1 to 24.2) and 15.8 months (12 to 24.8) for chronic infections with unresectable components. overall non-recurrence rates for acute infection was 92.3% (24/26) but only 44.4% (4/9) for chronic infections with unresectable components. The majority of patients remained on suppressive oral antibiotics. Musculoskeletal Infection Society (MSIS) host grade was a significant indicator of failure (p < 0.001). conclusion The addition of io vancomycin at the time of DAiR was shown to be safe with improved results compared to current literature using standard DAiR without io antibiotic administration. Use of this technique in chronic infections should be applied with caution. While these results are encouraging, this technique requires longer follow-up before widespread adoption.